Intrinsic Value of S&P & Nasdaq Contact Us

Arch Therapeutics, Inc. ARTH OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
31/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Arch Therapeutics, Inc. (ARTH) has 12 known insider and institutional holders on record. The largest holder is DAVIS RICHARD E with 700,000 shares. Other notable holders include Yrigoyen Dan and COTTER WILLIAM M.

ARTH Insider Ownership

Top Holder
DAVIS RICHARD E
700,000 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Davis Richard E CFO & Treasurer 700,000 2019-12-23
100%
2 Yrigoyen Dan Vice President, Sales 500,000 2022-11-10
71%
3 Cotter William M Chief Operating Officer 350,000 2014-03-25
50%
4 Dhillon Punit Director 250,000 2022-11-10
36%
5 Sulat James R Director 250,000 2021-10-01
36%
6 Fish Guy L. Director 250,000 2022-11-10
36%
7 Dhillon Avtar S Director 220,000 2018-07-20
31%
8 Barber Alan Chief Financial Officer 125,000 2013-09-11
18%
9 Rosenthal Arthur L Director 100,000 2015-01-23
14%
10 Hicks Laurence Director 10,292 2023-09-08
1%
11 Abrams Michael S Chief Financial Officer 10,292 2023-09-08
1%
12 Norchi Terrence W President and Chief Executive 6,862 2023-09-08
1%

No ownership data available for ARTH.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message